Role of non-macrophage cell-derived HMGB1 in oxaliplatin-induced peripheral neuropathy and its prevention by the thrombin/thrombomodulin system in rodents: negative impact of anticoagulantsMaho Tsubota, Atsufumi Kawabata|Journal of Neuroinflammation|2019Cited by 45
<scp>AKAP</scp>‐dependent sensitization of<scp>Ca</scp><sub>v</sub>3.2 channels via the<scp>EP</scp><sub>4</sub>receptor/c<scp>AMP</scp>pathway mediates<scp>PGE</scp><sub>2</sub>‐induced mechanical hyperalgesiaFumiko Sekiguchi, Atsufumi Kawabata|British Journal of Pharmacology|2012Cited by 37
Proteinase-Activated Receptor-2–Triggered Prostaglandin E2 Release, but Not Cyclooxygenase-2 Upregulation, Requires Activation of the Phosphatidylinositol 3–Kinase / Akt / Nuclear Factor-κB Pathway in Human Alveolar Epithelial CellsKazumi Moriyuki, Atsufumi Kawabata|Journal of Pharmacological Sciences|2009Cited by 22
Caspase-Dependent HMGB1 Release from Macrophages Participates in Peripheral Neuropathy Caused by Bortezomib, a Proteasome-Inhibiting Chemotherapeutic Agent, in MiceMaho Tsubota, Atsufumi Kawabata|Cells|2021Cited by 14